Metraipolis › archive › dc_c2e8676ee82d

Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving… — Europe PMC PMID:41008905

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41008905
DOI
10.3390/cancers17183063
License (as archived)
solo-consultazione
Archived
2026-11-09T21:05:51.380Z
SHA-256 of the archived text
c9de68c293056e94a1233b3d46940cbc5b533ea53892f8aca4050073b80faf19
Stable URL of this page
https://metraipolis.com/documento/dc_c2e8676ee82d

How to cite

Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving… — Europe PMC PMID:41008905 — Europe PMC (en), https://europepmc.org/article/MED/41008905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2e8676ee82d (Metraipolis archive dc_c2e8676ee82d, sha256 c9de68c293056e94a1233b3d46940cbc5b533ea53892f8aca4050073b80faf19)
BibTeX
@misc{dcc2e8676ee82d,
  title = {Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving… — Europe PMC PMID:41008905},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008905},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2e8676ee82d; sha256 c9de68c293056e94a1233b3d46940cbc5b533ea53892f8aca4050073b80faf19},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008905. Agents can read the archived copy with the MCP tool read_document.